{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T02:52:36Z","timestamp":1686797556129},"reference-count":21,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["mol clin onc"],"DOI":"10.3892\/mco.2018.1700","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T12:32:26Z","timestamp":1534422746000},"source":"Crossref","is-referenced-by-count":1,"title":["High promoter activity of cytokeratin\u201119 gene in cholangiocarcinoma"],"prefix":"10.3892","author":[{"given":"Jian","family":"Qin","sequence":"first","affiliation":[{"name":"Department of Surgery, First People's Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Surgery, First People's Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Surgery, First People's Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qu","family":"Cai","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi\u2011Hai","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Surgery, First People's Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,8,16]]},"reference":[{"key":"key20200713202058_b1-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/hep.20537","article-title":"Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy","volume":"41","author":"Sirica","year":"2005","journal-title":"Hepatology"},{"key":"key20200713202058_b2-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatology"},{"key":"key20200713202058_b3-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(05)63789-0","article-title":"Increase in primary liver cancer in the UK, 1979\u201394","volume":"350","author":"Taylor-Robinson","year":"1997","journal-title":"Lancet"},{"key":"key20200713202058_b4-mco-0-0-1700","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/0008-5472.546.65.2","article-title":"Effective gene therapy of biliary tract cancers by a conditionally replicative adenovirus expressing uracil phosphoribosyltransferase: Significance of timing of 5-fluorouracil administration","volume":"65","author":"Seo","year":"2005","journal-title":"Cancer Res"},{"key":"key20200713202058_b5-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1006\/mthe.2001.0303","article-title":"Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters","volume":"3","author":"Nakano","year":"2001","journal-title":"Mol Ther"},{"key":"key20200713202058_b6-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s004230000189","article-title":"Prognostic factors and long-term results after surgery for gallbladder carcinoma: A retrospective study of 127 patients","volume":"386","author":"Schauer","year":"2001","journal-title":"Langenbecks Arch Surg"},{"key":"key20200713202058_b7-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/jhep.2001.28198","article-title":"Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm","volume":"34","author":"Hayashi","year":"2001","journal-title":"Hepatology"},{"key":"key20200713202058_b8-mco-0-0-1700","first-page":"281","article-title":"Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers","volume":"7","author":"Itoi","year":"2001","journal-title":"Int J Mol Med"},{"key":"key20200713202058_b9-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0168-8278(01)00167-2","article-title":"Cloning and characterization of the 5\u2032-flanking region of human cytokeratin 19 gene in human cholangiocarcinoma cell line","volume":"35","author":"Kagaya","year":"2001","journal-title":"J Hepatol"},{"key":"key20200713202058_b10-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1034\/j.1600-0676.2000.020003216.x","article-title":"Increased midkine expression in intrahepatic cholangiocarcinoma: Immunohistochemical and in situ hybridization analyses","volume":"20","author":"Kato","year":"2000","journal-title":"Liver"},{"key":"key20200713202058_b11-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1440-1827.2002.01414.x","article-title":"Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: Its relationship with tumor progression and prognosis","volume":"52","author":"Tamada","year":"2002","journal-title":"Pathol Int"},{"key":"key20200713202058_b12-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1053\/jhep.2001.26212","article-title":"Gene therapy for hepatocellular carcinoma-teaching old dogs new tricks","volume":"34","author":"Afford","year":"2001","journal-title":"Hepatology"},{"key":"key20200713202058_b13-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jhep.2005.06.007","article-title":"Selection of tumour specific promoters for adenoviral gene therapy of cholangiocarcinoma","volume":"44","author":"Lie-A-Ling","year":"2006","journal-title":"J Hepatol"},{"key":"key20200713202058_b14-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S1091-255X(02)00437-7","article-title":"Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement","volume":"7","author":"Nagi","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"key20200713202058_b15-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/1098-2388(200009)19:2<156::AID-SSU8>3.0.CO;2-#","article-title":"Cholangiocarcinoma of the extrahepatic bile ducts","volume":"19","author":"Jarnagin","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"key20200713202058_b16-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1517\/14712598.4.5.683","article-title":"Tissue-specific promoters for cancer gene therapy","volume":"4","author":"Saukkonen","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"key20200713202058_b17-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/sj.gt.3302385","article-title":"Evaluation of tumor-specific promoter activities in melanoma","volume":"12","author":"Lu","year":"2005","journal-title":"Gene Ther"},{"key":"key20200713202058_b18-mco-0-0-1700","first-page":"334","article-title":"Prostate-specific antigen promoter\/enhancer driven gene therapy for prostate cancer: Construction and testing of a tissue-specific adenovirus vector","volume":"60","author":"Latham","year":"2000","journal-title":"Cancer Res"},{"key":"key20200713202058_b19-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0168-9525(99)01950-2","article-title":"Gene therapy: Designer promoters for tumour targeting","volume":"16","author":"Nettelbeck","year":"2000","journal-title":"Trends Genet"},{"key":"key20200713202058_b20-mco-0-0-1700","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1172\/JCI9180","article-title":"Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen","volume":"106","author":"Kurihara","year":"2000","journal-title":"J Clin Invest"},{"key":"key20200713202058_b21-mco-0-0-1700","first-page":"3181","article-title":"A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer","volume":"63","author":"Wirth","year":"2003","journal-title":"Cancer Res"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T12:37:13Z","timestamp":1661776633000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2018.1700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,16]]},"references-count":21,"URL":"https:\/\/doi.org\/10.3892\/mco.2018.1700","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,16]]}}}